InvestorsHub Logo
Followers 33
Posts 5288
Boards Moderated 0
Alias Born 01/23/2019

Re: rafunrafun post# 289736

Tuesday, 08/04/2020 2:40:17 PM

Tuesday, August 04, 2020 2:40:17 PM

Post# of 425639
raf, correct me if I'm wrong but during the AMA conference back in Nov 2019 Hikma made a presentation that shocked everyone with there forecast of a generic vascepa of somewhere in the neighborhood of $750 mill annual revs. Also, Hikma's FDA approval of ANDA for GV came shortly after Du's disastrous decision. I believe Hikma was fully prepared to win the court case. Plus they have a supplier lined up. Not so sure about Dr Reddys since they have been extremely quiet during all this time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News